Short-sellers have been ramping up their positions in both Editas Medicine and Bluebird Bio lately. With multiple options on the table, Editas and Bluebird could both blaze the comeback trail. A short ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
bluebird bio reported a net income of $21.2 million in Q1 2023, a significant turnaround from a net loss of $122.2 million in the same period in 2022, primarily due to a one-time gain from the sale of ...
Recent events have shown us that meme stock mania is never dead, only paused. The latest meme rally has faded, but retail traders are on the lookout for the next stock to go parabolic. For those ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results